IpsiHand® is an FDA-cleared, non-invasive treatment of stroke. See if you qualify →

  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?

IpsiHand Prescription Information

When completing the IpsiHand Rx form, enter the full ICD-10 diagnostic code below. Add the highest specificity with all numbers in the code.

I69.051 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage, affecting right dominant side
I69.052 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side
I69.053 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side
I69.054 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side
I69.151 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side
I69.152 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side
I69.153 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side
I69.154 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side
I69.251 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side
I69.252 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side
I69.253 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side
I69.254 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side
I69.351 Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
I69.352 Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side
I69.353 Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side
I69.354 Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side
I69.851 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side
I69.852 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side
I69.853 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side
I69.854 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side

8091.949.V3.E

About IpsiHand
  • How It Works
  • Get IpsiHand
  • Testimonials
  • Orthoses vs Therapeutic Devices
Resources
  • Resource Library
  • Insurance Coverage
  • Veterans Benefits
  • IpsiHand FAQ
    • FAQ Healthcare Professionals
  • Stroke Insights and Answers
  • News & Articles
  • For Clinicians
Company
  • About Neurolutions
  • Team
  • Careers
  • Contact Us
  • Important Safety Information
  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy

.

  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Leo Petrossian

Leo Petrossian

Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intrapreneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.

Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.